Back to User profile » Prof. Dr. Elif Şen
Papers published by Prof. Dr. Elif Şen:
Reliability of Pulmonary Function Tests in Patients with Chronic Obstructive Pulmonary Disease
Arslan F, Şen E, Şirin B, Köktürk N, Ulubay G, Aydogan Eroglu S, Gemicioglu B, Sönmez Ö, Şerifoğlu İ, Dilektasli AG, Öztürk Şahin B, Doğan İ, Gürhan N, Günen H, Ensen N
International Journal of Chronic Obstructive Pulmonary Disease 2026, 21:554115
Published Date: 21 January 2026
Validation Study of Rome Criteria for Assessing COPD Exacerbation Severity and Predicting Clinical Outcomes: Turkish Thoracic Society COPD Assembly
Baha A, Baysan C, Nayci SA, Ozgur ES, Karamustafalioglu T, Sen E, Selcuk E, Mit G, Alpaydin AO, Ozturk B, Karabacak KT, Kokturk N, Akbulut S, Baydar O, Varol Y, Kodalak S, Esendagli D, Gurgun A, Emdadian E, Toreyin ZN, Alkan A, Sertcelik U, Ozmen I, Elabed EU, Kilic H, Polatli M, Hilmioglu O
International Journal of Chronic Obstructive Pulmonary Disease 2025, 20:3993-4003
Published Date: 10 December 2025
Risk of Pneumonia in Patients with COPD Initiating Fixed Dose Inhaled Corticosteroid (ICS) / Long-Acting Bronchodilator (LABD) Formulations Containing Extrafine Beclometasone Dipropionate versus Patients Initiating LABD Without ICS
Price D, Henley W, Cançado JED, Fabbri LM, Kerstjens HA, Papi A, Roche N, Şen E, Singh D, Vogelmeier CF, Nudo E, Carter V, Skinner D, Vella R, Soriano JB, Kots M, Georges G
Pragmatic and Observational Research 2024, 15:1-16
Published Date: 20 January 2024
The CO-MIND Study: Chronic Obstructive Pulmonary Disease Management in Daily Practice and Its Implications for Improved Outcomes According to GOLD 2019 Perspective
Gunen H, Kokturk N, Naycı S, Ozkaya S, Yıldız BP, Turan O, Gumus A, Akgun M, Gurgun A, Ogus C, Mirici A, Sen E, Bayram N, Eken V, Erkus H
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:1883-1895
Published Date: 18 August 2022
Interclass Difference in Pneumonia Risk in COPD Patients Initiating Fixed Dose Inhaled Treatment Containing Extrafine Particle Beclometasone versus Fine Particle Fluticasone [Corrigendum]
Price DB, Henley W, Cançado JED, Fabbri LM, Kerstjens HA, Papi A, Roche N, Şen E, Singh D, Vogelmeier CF, Barille S, Nudo E, Carter V, Skinner D, Vella R, Georges G
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:489-490
Published Date: 7 March 2022
Interclass Difference in Pneumonia Risk in COPD Patients Initiating Fixed Dose Inhaled Treatment Containing Extrafine Particle Beclometasone versus Fine Particle Fluticasone
Price DB, Henley W, Cançado JED, Fabbri LM, Kerstjens HA, Papi A, Roche N, Şen E, Singh D, Vogelmeier CF, Barille S, Nudo E, Carter V, Skinner D, Vella R, Georges G
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:355-370
Published Date: 15 February 2022
Adherence to GOLD guideline treatment recommendations among pulmonologists in Turkey
Sen E, Guclu SZ, Kibar I, Ocal U, Yilmaz V, Celik O, Cimen F, Topcu F, Orhun M, Tereci H, Konya A, Ar I, Saryal S
International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:2657-2663
Published Date: 10 December 2015